Abbott enters into agreement with Inpeco to expand laboratory automation capabilites
"Laboratories are looking at automation to help them address labor shortages, improve safety and reduce errors," said Douglas C. Bryant, vice president, Global Commercial Operations, Diagnostics Division, Abbott. "Many of Abbott's diagnostic instruments and software already address some of these challenges. However, this agreement allows Abbott to offer a broader range of automation solutions that can be customized to support the lab's unique workflow needs."
Under the terms of the agreement, Abbott obtains non-exclusive rights to distribute and market Inpeco laboratory automation equipment worldwide. Additionally, Abbott will have access to new lab automation technologies developed by Inpeco. This gives Abbott the ability to incorporate technological advancements, including information technology and robotics, into future automation solutions.
Abbott and Inpeco will partner to design, develop and commercialize interfaces between Abbott's ARCHITECT® and CELL-DYN® family of analyzers and Inpeco's suite of modular, laboratory automation components to create an enhanced pre/post-analytical workcell, an immunochemistry track workcell, a hematology track workcell or a customized combination of the three. Abbott will also offer laboratories additional flexibility by utilizing an open architecture. This open-system approach gives laboratories the ability to customize a system that best meets their needs.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
LAUDA.LIVE by LAUDA
LAUDA.LIVE - The digital platform for your device management
Comprehensive fleet management options for every LAUDA device - with and without IoT connectivity
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.